Nitric oxide donating derivatives for the treatment of cardiovascular disorders

Details for Australian Patent Application No. 2004277291 (hide)

Owner Resverlogix Corp.

Inventors Tucker, Joe; McCaffrey, David Robert; Wong, Norman

Agent Cullen & Co

Pub. Number AU-A-2004277291

PCT Pub. Number WO2005/032559

Priority 60/509,156 07.10.03 US; 10/762,796 22.01.04 US; 10/807,800 24.03.04 US

Filing date 7 October 2004

Wipo publication date 14 April 2005

International Classifications

C07D 311/32 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/032559 Priority application(s): WO2005/032559

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277302-Biocompatible, biostable coating of medical surfaces

2004277290-Methods for treating acute and overuse sprain and strain using hyaluronic acid